Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells

Nitric oxide synthase (NOS) isoenzymes generate nitric oxide (NO), a sensitive multifunctional intercellular signal molecule. High NO levels are produced by an inducible NOS (iNOS) in activated macrophages in response to proinflammatory agents, many of which also regulate local bone metabolism. NO is a potent inhibitor of osteoclast bone resorption, whereas inhibitors of NOS promote bone resorption both in vitro and in vivo. The possibility that osteoclasts, like macrophages, express a regulated iNOS and produce NO as a potential autocrine signal following inflammatory stimulation was investigated in well‐characterized avian marrow‐derived osteoclast‐like cells. NO production (reflected by medium nitrite levels) was markedly elevated in these cells by the proinflammatory agents lipopolysaccharide (LPS) and the synergistic action of IL‐1α, TNFα, and IFNγ. Inhibitors of NOS activity (aminoguanidine, L‐NAME) or iNOS induction (dexamethasone, TGFβ) reduced LPS‐stimulated nitrite production. LPS also increased the NOS‐associated diaphorase activity of these cells and their reactivity with anti‐iNOS antibodies. RT‐PCR cloning, using avian osteoclast‐like cell RNA and human iNOS primers, yielded a novel 900 bp cDNA with high sequence homology (76%) to human, rat, and mouse iNOS genes. In probing osteoclast‐like cell RNA with the PCR‐derived iNOS cDNA, a 4.8 kb mRNA species was detected whose levels were greatly increased by LPS. Induction of iNOS mRNA by LPS, or by proinflammatory cytokines, occurred prior to the rise of medium nitrite in time course studies and was diminished by dexamethasone. Moreover, osteoclast‐like cells demonstrated an upregulation of NO production and iNOS mRNA by IL‐8 and IL‐10, regulatory mechanism's not previously described. It is concluded that osteoclast‐like cells express a novel iNOS that is upregulated by inflammatory mediators, leading to NO production. Therefore, NO may serve as both a paracrine and autocrine signal for modulating osteoclast bone resorption. © 1996 Wiley‐Liss, Inc.